Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

4510 results

Sort By:

Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women

Study ID: NCT06904365
Start Date: 2025-04-01
End Date: 2026-04-15
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

10

Intervention / Treatment

HyperSight cone beam computed tomography (CBCT) scan

ETHOS 2.0

Sponsor

Washington University School of Medicine

Source: clinicaltrials.gov

Share:
Add to list

Multidisciplinary Approach for Treat To Target In Rheumatoid Arthritis

Study ID: NCT02720874
Start Date: 2025-06-01
End Date: 2027-12-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

150

Intervention / Treatment

Rheumatoid arthritis educational booklet

Multidisciplinary rheumatologic care

Nurse education and monthly calls

Monthly healthcare coordinator calls

Technology-based symptom monitoring and reporting

Sponsor

Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Effect of Neuromodulation and Therapeutic Exercise in Urinary Incontinence

Study ID: NCT06783374
Start Date: 2025-04-10
End Date: 2026-11-10
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

63

Intervention / Treatment

Neuromodulation

Exercise

Exercise control group

Sham Neuromodulation

Sponsor

Catholic University Foundation of Valencia San Vicente Mártir

Source: clinicaltrials.gov

Share:
Add to list

ALS20-101 Lentiviral Gene Therapy for Beta Thalassemia

Study ID: NCT06364774
Start Date: 2025-04-01
End Date: 2027-12-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

12

Intervention / Treatment

ALS20

Sponsor

Children's Hospital of Philadelphia

Source: clinicaltrials.gov

Share:
Add to list

Cannabis for Obesity Trial

Study ID: NCT06137365
Start Date: 2025-05
End Date: 2026-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

40

Intervention / Treatment

Cannabis

Placebo

Sponsor

University of Kentucky

Source: clinicaltrials.gov

Share:
Add to list

ELISA in Relapsed/Refractory MM

Study ID: NCT06832865
Start Date: 2026-08-01
End Date: 2028-12-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

30

Intervention / Treatment

Follower

Isatuximab SC

Isatuximab SC-OBDS

Sponsor

Massachusetts General Hospital

Source: clinicaltrials.gov

Share:
Add to list

ImmunoBoost: the Lymphatic Osteopathic Manipulative Treatment Protocol Study

Study ID: NCT06565065
Start Date: 2025-04-05
End Date: 2025-12-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment

Osteopathic Manipulative Treatment (OMT)

Sham Light Touch

Exercise Protocol

Sponsor

Western University of Health Sciences

Source: clinicaltrials.gov

Share:
Add to list

The TEAM Study - Treatment Efficacy for Autism/Attention Using Mixed Amphetamine

Study ID: NCT06853665
Start Date: 2025-05-01
End Date: 2029-04-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

196

Intervention / Treatment

Adderall XR (mixed salts amphetamine)

Placebo

Sponsor

Gagan Joshi

Source: clinicaltrials.gov

Share:
Add to list

Study of Emotional Regulation and Underlying Prefrontal Activity in Binge Eating Disorder

Study ID: NCT06864065
Start Date: 2025-04-01
End Date: 2026-10-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

80

Intervention / Treatment

Emotion regulation task (fNIRS recording during the emotional regulation task)

Sponsor

Besancon University Hospital Center

Source: clinicaltrials.gov

Share:
Add to list

First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer

Study ID: NCT06799065
Start Date: 2025-04-30
End Date: 2027-08-30
Study Type

Interventional

Study Phase

Phase1

No. of Participants

65

Intervention / Treatment

ATX-295

Sponsor

Accent Therapeutics

Source: clinicaltrials.gov

Share:
Add to list